Elixirgen Therapeutics is currently enrolling patients in its Phase 1/2 trial evaluating EXG-34217 in patients with telomere biology disorders at Cincinnati Children’s Hospital Medical CenterBALTIMORE ...
European Commission approves OMP Designation for NLX-112 (befiradol) following compelling results in studies funded by the US Dept of De ...
Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing ...
Capricor announced it intends to file a BLA for deramiocel for treatment of patients with DMD cardiomyopathy. Click here to ...
The novel agent LP-184 has been granted rare pediatric disease designations in malignant rhabdoid tumors, rhabdomyosarcoma, ...
The U.S. Food and Drug Administration approved IntraBio's drug for a rare and fatal genetic disorder, the health regulator ...
Whether we are predisposed to particular diseases depends to a large extent on the countless variants in our genome. However, ...
Miplyffa treats Niemann-Pick disease type C, which progressively impacts the abilities to speak, swallow, and walk or move ...
Cowboy State Mine area The Cowboy State Mine project is the first step in a multi-phased approach to developing the Halleck Creek deposit, a significant rare earths asset for the United States.
The price of the flights, furniture or insurance you buy online may be controlled by semi-autonomous "black boxes". These AI-powered pricing algorithms learn how to improve a seller's revenues by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback